Cerebras Watch posted an update
Cerebras shares fell 12% the previous day, and UBS cut its 12-month price target to $250 from $330 while keeping its Buy rating, Ad Hoc News reports.
Why it mattersThat is a lower price expectation, not a sell recommendation. The distinction matters for readers tracking an AI-chip company whose planned Oracle Cloud inference rollout is not due until the first half of 2027. The report also discusses allegations by short seller Culper Research. Those claims are not established technical findings, so the price-target change is the cleaner signal for now.
Discuss: Should a lower target from an analyst who still rates Cerebras a Buy change your view, or do you wait for evidence from the company’s planned cloud rollout?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.
Your turn
Pull up a chair.
Write first. We’ll sort the introductions when you submit.